Study reveals new possibility of reversing damage caused by MS

December 5, 2010
Nerve fibres in rodents showing remyelination after exposure to RXR agonist in culture. Picture by Dr Andrew Jarjour, University of Edinburgh.

Damage caused by multiple sclerosis could be reversed by activating stem cells that can repair injury in the central nervous system, a study has shown.

Researchers from the Universities of Cambridge and Edinburgh have identified a mechanism essential for regenerating insulating layers – known as myelin sheaths – that protect nerve fibres in the brain. In additional studies in rodents, they showed how this mechanism can be exploited to make the brain's own stem cells better able to regenerate new myelin.

In multiple sclerosis, loss of myelin leads to the nerve fibres in the brain becoming damaged. These nerve fibres are important as they send messages to other parts of the body.

The scientists believe that this research will help in identifying drugs to encourage myelin repair in multiple sclerosis patients.

Professor Robin Franklin, Director of the MS Society's Cambridge Centre for Myelin Repair at the University of Cambridge, said: "Therapies that repair damage are the missing link in treating multiple sclerosis. In this study we have identified a means by which the brain's own can be encouraged to undertake this repair, opening up the possibility of a new regenerative medicine for this devastating disease."

The study, funded by the MS Society in the UK and the National Multiple Sclerosis Society in America, is published in Nature Neuroscience.

Professor Charles ffrench-Constant, of the University of Edinburgh's MS Society Centre for Multiple Sclerosis Research, said: "The aim of our research is to slow the progression of multiple sclerosis with the eventual aim of stopping and reversing it. This discovery is very exciting as it could potentially pave the way to find drugs that could help repair damage caused to the important layers that protect nerve cells in the brain."

affects almost 100,000 people in the UK and several million worldwide. It often targets young adults between the ages of 20 and 40.

More information: The paper 'Retinoid X receptor gamma signaling accelerates CNS remyelination' will be published in the 05 December 2010 edition of Nature Neuroscience.

Related Stories

Recommended for you

Placebo sweet spot for pain relief found in brain

October 27, 2016

Scientists have identified for the first time the region in the brain responsible for the "placebo effect" in pain relief, when a fake treatment actually results in substantial reduction of pain, according to new research ...

Team announces mapping of the mouse cortex in 3-D

October 27, 2016

The Allen Institute for Brain Science has completed the three-dimensional mapping of the mouse cortex as part of the Allen Mouse Common Coordinate Framework (CCF): a standardized spatial coordinate system for comparing many ...

Neuro chip records brain cell activity

October 26, 2016

Brain functions are controlled by millions of brain cells. However, in order to understand how the brain controls functions, such as simple reflexes or learning and memory, we must be able to record the activity of large ...


Adjust slider to filter visible comments by rank

Display comments: newest first

5 / 5 (4) Dec 05, 2010
While I have supported MS/MD and other disease fighting organizations for decades, I always figured it was more for show and emotional support of the affected. It was my belief that it would take nano level research to fix these issues, and the medieval tools available even 10 years ago were inadequate to effect any consequential change in these viral type diseases. At last the power to use a real tool like stem cells is finally being awakened.
5 / 5 (1) Dec 06, 2010
I'm secondary progressive MS patient, got happy from this news.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.